Presentation by Silvia Millán Martín, NIBRT: The role of MAM in advancing innovative analytical strategies for biotherapeutics characterization and the…
Presentation by Mitul Patel, GSK: Incorporating Mass Spectrometry into Analytical Strategies to Early De-risk the mAb Discovery and CMC processes
Presentation by Adam Evans, Janssen: Multi-Attribute Monitoring from Development to Commercial QC
Presentation by Diane McCarthy, US Pharmacopeia: USP Standards to Support Multi-Attribute Methods
Presentation by John Schiel, NIST, Mass Spectrometry as a Disruptive Technology for Emerging Modalities
Presentation by Pavel Bondarenko, Amgen, Identification of Critical Chemical Modifications and Paratope Mapping by SEC of Stressed Antibody-target Complexes
MAM Consortium Presentation by Andrew Mahan, Janssen: Comprehensive Characterization of mAbs and Multispecifics with Multiple Technologies, CE, iCIEF-MS and Novel…
MAM Consortium Presentation by Josh Eckels and Danielle Faivre, LabKey: Skyline and Panorama Support for MAM Analysis
MAM Consortium Presentation by Cinzia Stella, Genentech: Online HPLC-HRMS Platform: The Next-Generation Process Analytical Technology Tool for Real-Time Monitoring of…
MAM Consortium Presentation by Prof. Sunny Zhou, Northeastern University: Chemo-Enzymatic Approaches for the Analysis of Product Quality Attributes (PQAs)